Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.

MLA

Stöger, J.Lauran, et al. “Deleting Myeloid IL-10 Receptor Signalling Attenuates Atherosclerosis in LDLR-/- Mice by Altering Intestinal Cholesterol Fluxes.” Thrombosis and Haemostasis, vol. 116, no. 3, Aug. 2016, pp. 565–77. EBSCOhost, https://doi.org/10.1160/TH16-01-0043.

APA

Stöger, J. L., Boshuizen, M. C. S., Brufau, G., Gijbels, M. J. J., Wolfs, I. M. J., van der Velden, S., Pöttgens, C. C. H., Vergouwe, M. N., Wijnands, E., Beckers, L., Goossens, P., Kerksiek, A., Havinga, R., Müller, W., Lütjohann, D., Groen, A. K., & de Winther, M. P. J. (2016). Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes. Thrombosis and Haemostasis, 116(3), 565–577. https://doi.org/10.1160/TH16-01-0043

Chicago

Stöger, J Lauran, Marieke C S Boshuizen, Gemma Brufau, Marion J J Gijbels, Ine M J Wolfs, Saskia van der Velden, Chantal C H Pöttgens, et al. 2016. “Deleting Myeloid IL-10 Receptor Signalling Attenuates Atherosclerosis in LDLR-/- Mice by Altering Intestinal Cholesterol Fluxes.” Thrombosis and Haemostasis 116 (3): 565–77. doi:10.1160/TH16-01-0043.